Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 132

Sort by

Sort Order Select

Journal Articles

Extracavitary primary effusion lymphoma presenting as a thalamic mass in a patient with multicentric Castleman disease

Kritika Krishnamurthy, Vathany Sriganeshan

Blood (2020) 135 (14): 1190.

https://doi.org/10.1182/blood.2019004506

Published: 2020

Journal Articles

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

Juan Carlos Ramos, MD BS, Joseph Sparano, MD, Page C. Moore, PhD, Eric Siegel, Jeannette Y Lee, PhD, Erin G. Reid, MD MS, Richard F. Ambinder, MD, Amy Chadburn, MD, Paul G. Rubinstein, MD, Christine Durand, Ethel Cesarman, MD PhD, Lee Ratner, MD PhD, Robert A Baiocchi, MD PhD, David M. Aboulafia, MD, Lawrence D Kaplan, MD, Adam Capoferri, Ronald T. Mitsuyasu, MD, Ariela Noy, MD

Blood (2019) 134 (Supplement_1): 1588.

https://doi.org/10.1182/blood-2019-129687

Published: 2019

Journal Articles

Impact of Interim FDG-PET (iPET) in the Outcomes of Patients with Aggressive B-Cell Lymphomas Receiving DA-EPOCH-R

Vania Phuoc, MD, Leidy Isenalumhe, MD, Hayder Saeed, MD, Celeste Bello, MD, Bijal Shah, MD, Lubomir Sokol, MD PhD, Julio Chavez

Blood (2019) 134 (Supplement_1): 2898.

https://doi.org/10.1182/blood-2019-122393

Published: 2019

Journal Articles

Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma

Juan Carlos Ramos, MD BS, Richard F. Ambinder, MD, Joseph Sparano, MD, Jeannette Y Lee, PhD, Lawrence D Kaplan, MD, William Wachsman, MD PhD, David M. Aboulafia, MD, Ariela Noy, MD, Lee Ratner, MD PhD, David H. Henry, MD, Amy Chadburn, MD, Ethel Cesarman, MD PhD, Ronald T. Mitsuyasu, MD

Blood (2019) 134 (Supplement_1): 2872.

https://doi.org/10.1182/blood-2019-123558

Published: 2019

Journal Articles

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Jomy George, PharmD, Maryalice Stetler-Stevenson, MD PhD, Mark Raffeld, MD, Constance M. Yuan, MD PhD, Joseph Ziegelbauer, PhD, Frank Maldarelli, MD PhD, William D. Figg, PharmD, Cody Peer, PhD, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2019) 134 (Supplement_1): 4096.

https://doi.org/10.1182/blood-2019-122070

Published: 2019

Journal Articles

Short-Course Therapy in Newly Diagnosed Immunodeficiency-Associated Aggressive B-Cell Lymphoma

Rami Alsharif, MD, Samah Nassereddine, MD, Esma Akin, MD, Donald Karcher, MD, Mitchell Smith, MD PhD, Eduardo Sotomayor, MD, Kieron Dunleavy, MD

Blood (2019) 134 (Supplement_1): 5355.

https://doi.org/10.1182/blood-2019-124081

Published: 2019

Journal Articles

Viral, immunologic, and clinical features of primary effusion lymphoma

Kathryn Lurain, Mark N. Polizzotto, Karen Aleman, Manisha Bhutani, Kathleen M. Wyvill, Priscila H. Gonçalves, Ramya Ramaswami, Vickie Ann Marshall, Wendell Miley, Seth M. Steinberg, Richard F. Little, Wyndham Wilson, Armando C. Filie, Stefania Pittaluga, Elaine S. Jaffe, Denise Whitby, Robert Yarchoan, Thomas S. Uldrick

Blood (2019) 133 (16): 1753–1761.

https://doi.org/10.1182/blood-2019-01-893339

Published: 2019

Journal Articles

SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy?

Hilmar Quentmeier, PhD, Claudia Pommerenke, PhD, Wilhelm G Dirks, PhD, Vivien Hauer, Max Koeppel, PhD, Stefan Nagel, PhD, Michaela Scherr, PhD, Margarete Zaborski, Hans G. Drexler, MD PhD

Blood (2018) 132 (Supplement 1): 5300.

https://doi.org/10.1182/blood-2018-99-110054

Published: 2018

Journal Articles

Demographics and Survival in Primary Effusion Lymphoma: SEER Database Analysis

John Khoury, MD, Christopher Allen Willner, DO, Bolanle Gbadamosi, MD, Susanna Gaikazian, MD, Ishmael Jaiyesimi, DO, MS

Blood (2018) 132 (Supplement 1): 5397.

https://doi.org/10.1182/blood-2018-99-115473

Published: 2018

Journal Articles

The Analysis of HIV-Associated Lymphoma in Japan

Shotaro Hagiwara, MD PhD, Kentaro Yoshinaga, MD PhD, Masayuki Shiseki, MD, Junji Tanaka, MD PhD, Seiji Okada, MD PhD

Blood (2018) 132 (Supplement 1): 5315.

https://doi.org/10.1182/blood-2018-99-114060

Published: 2018

Journal Articles

IL-13 Expression Characterizes Effusions Associated with Primary Effusion Lymphoma but Not Other Disorders Caused By Kaposi Sarcoma Herpesvirus (KSHV)

Ramya Ramaswami, MBBS, MPH, Kathryn Lurain, MD MPH, Vickie Marshall, Nazzarena Labo, MD PhD, Anaida Widell, Matthew Lindsley, Mark N. Polizzotto, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2018) 132 (Supplement 1): 4137.

https://doi.org/10.1182/blood-2018-99-117668

Published: 2018

Journal Articles

Multicentric MFI30 Study: Standardization of CD30 Expression By Flow Cytometry in Non-Hodgkin Lymphoma

Agathe Pruvot Debliquis, pharmD, Lucile Baseggio, MD, Marie-Christine Jacob, Sabrina Bouyer, Franck Genevieve, MD PhD, Julien Guy, MD, Caroline Mayeur-Rousse, MD, Nicolas Chapuis, PharmD, PhD, Hind Bennani, Thomas Matthes, MD, Bernard Drenou

Blood (2018) 132 (Supplement 1): 2869.

https://doi.org/10.1182/blood-2018-99-115990

Published: 2018

Journal Articles

Biology and management of primary effusion lymphoma

Kazuyuki Shimada, Fumihiko Hayakawa, Hitoshi Kiyoi

Blood (2018) 132 (18): 1879–1888.

https://doi.org/10.1182/blood-2018-03-791426

Published: 2018

Journal Articles

CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma

Ajinkya Patil, Mark Manzano, Eva Gottwein

Blood (2018) 132 (6): 577–586.

https://doi.org/10.1182/blood-2018-01-828418

Published: 2018

Includes: Supplemental data

Journal Articles

Narciclasine Display Preferential Pre-Clinical Activity Against KSHV-Associated Primary Effusion Lymphoma By Targeting MYC Via NF-κB

Ramakrishnan Gopalakrishnan, PhD, Hittu Matta, PhD, Sunju Choi, PhD, Preet M. Chaudhary, MD PhD

Blood (2017) 130 (Supplement 1): 2807.

https://doi.org/10.1182/blood.V130.Suppl_1.2807.2807

Published: 2017

Journal Articles

Arsenic Trioxide and Lenalidomide: A Promising Combination Therapy for Primary Effusion Lymphoma

Rita Hleihel, Nadim Tawil, Martin Karam, Raghida Abou Merhi, Ali Bazarbachi, MD PhD, Hiba El Hajj, Dr

Blood (2017) 130 (Supplement 1): 2817.

https://doi.org/10.1182/blood.V130.Suppl_1.2817.2817

Published: 2017

Journal Articles

Mechanism of Pax5 Down-Regulation and Its Function in Primary Effusion Lymphoma

Hiroki Goto, MD, PhD, Ryusho Kariya, PhD, Eriko Kudo, PhD, Seiji Okada, MD, PhD

Blood (2017) 130 (Supplement 1): 3791.

https://doi.org/10.1182/blood.V130.Suppl_1.3791.3791

Published: 2017

Journal Articles

Outcomes and Risks of Allogeneic Hematopoietic Stem Cell Transplant for Hematological Malignancies in Patients with HIV Infection

Shukaib Arslan, MD, Nathan W. Cummins, MD, Stacey A. Rizza, MD, Andrew D. Badley, MD, Mark R. Litzow, MD, Willis H. Navarro, MD, Shahrukh K. Hashmi, MDMPH

Blood (2017) 130 (Supplement 1): 4596.

https://doi.org/10.1182/blood.V130.Suppl_1.4596.4596

Published: 2017

Journal Articles

Coinfection with HCV or HBV Increases the Risk of Lymphoma in HIV-Positive Patients: A Combined Analysis of the Lymphovir-ANRS-CO16 and Fhdh-ANRS-CO4 Cohorts

Blood (2017) 130 (Supplement 1): 1003.

https://doi.org/10.1182/blood.V130.Suppl_1.1003.1003

Published: 2017

Journal Articles

An intrasinusoidal extracavitary variant of primary effusion lymphoma

Anna S. Nam, Wayne Tam

Blood (2017) 130 (6): 836.

https://doi.org/10.1182/blood-2017-04-780593

Published: 2017

NARROW

Extracavitary primary effusion lymphoma presenting as a thalamic mass in a patient with multicentric Castleman disease

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

Impact of Interim FDG-PET (iPET) in the Outcomes of Patients with Aggressive B-Cell Lymphomas Receiving DA-EPOCH-R

Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's Lymphoma

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Short-Course Therapy in Newly Diagnosed Immunodeficiency-Associated Aggressive B-Cell Lymphoma

Viral, immunologic, and clinical features of primary effusion lymphoma

SLAMF7 in Primary Effusion Lymphoma, Target for Individualized Therapy?

Demographics and Survival in Primary Effusion Lymphoma: SEER Database Analysis

The Analysis of HIV-Associated Lymphoma in Japan

IL-13 Expression Characterizes Effusions Associated with Primary Effusion Lymphoma but Not Other Disorders Caused By Kaposi Sarcoma Herpesvirus (KSHV)

Multicentric MFI30 Study: Standardization of CD30 Expression By Flow Cytometry in Non-Hodgkin Lymphoma

Biology and management of primary effusion lymphoma

CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma

Narciclasine Display Preferential Pre-Clinical Activity Against KSHV-Associated Primary Effusion Lymphoma By Targeting MYC Via NF-κB

Arsenic Trioxide and Lenalidomide: A Promising Combination Therapy for Primary Effusion Lymphoma

Mechanism of Pax5 Down-Regulation and Its Function in Primary Effusion Lymphoma

Outcomes and Risks of Allogeneic Hematopoietic Stem Cell Transplant for Hematological Malignancies in Patients with HIV Infection

Coinfection with HCV or HBV Increases the Risk of Lymphoma in HIV-Positive Patients: A Combined Analysis of the Lymphovir-ANRS-CO16 and Fhdh-ANRS-CO4 Cohorts

An intrasinusoidal extracavitary variant of primary effusion lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only